Prognostic Impact of Direct <sup>131</sup>I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study.

Carrillo, José F; Vázquez-Romo, Rafael; Ramírez-Ortega, Margarita C; Carrillo, Liliana C; Gómez-Argumosa, Edgar; Oñate-Ocaña, Luis F

Prognostic Impact of Direct ¹³¹I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study.

Carrillo, José F; Vázquez-Romo, Rafael; Ramírez-Ortega, Margarita C; Carrillo, Liliana C; Gómez-Argumosa, Edgar; Oñate-Ocaña, Luis F.

Afiliação

Carrillo JF; Departmento de Cabeza y Cuello, Instituto Nacional de Cancerología, Mexico, Mexico.
Vázquez-Romo R; Subdirección de Cirugía, Instituto Nacional de Cancerología, Mexico, Mexico.
Ramírez-Ortega MC; Departmento de Farmacología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico, Mexico.
Carrillo LC; Departmento de Cuidados Paliativos, Instituto Nacional de Cancerología, Mexico, Mexico.
Gómez-Argumosa E; Departmento de Medicina Nuclear, Instituto Nacional de Cancerología, Mexico, Mexico.
Oñate-Ocaña LF; Subdirección de Investigación Clínica, Instituto Nacional de Cancerología, Mexico, Mexico.

Front Endocrinol (Lausanne) ; 10: 737, 2019.

Article em En | MEDLINE | ID: mdl-31736875

Palavras-chave

131I treatment; cohort studies; diagnostic whole body scan; differentiated thyroid cancer; thyroglobulin

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google